BCL2L1 and neoplasm: SF3B1 blockade also exerted important molecular actions involving the splicing modulation of two clinically relevant SVs of BCL2L1 (Bcl-xL and Bcl-xS) associated with cancer -development and known to play an oncogenic role and a tumor suppressor actions, respectively [6, 10].